Federico Sarabia-Navarro
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
Journal: PloS one
Published: April 23, 2018
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
Journal: PloS one
Published: November 28, 2017
Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
Journal: The Journal of rheumatology
Published: September 19, 2017
Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: May 12, 2016
Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis.
Journal: Reumatologia clinica
Published: January 26, 2016
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.
Journal: Pharmacogenomics
Published: April 01, 2015
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.
Journal: The pharmacogenomics journal
Published: October 09, 2014
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.
Journal: Arthritis research & therapy
Published: October 08, 2014
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.
Journal: Annals of the rheumatic diseases
Published: May 30, 2014
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.
Journal: Pharmacogenetics and genomics
Published: March 27, 2014
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Journal: Arthritis care & research
Published: January 22, 2014
Economic evaluation of rheumathoid arthritis monotherapy with tocilizumab and adalimumab
Journal: Revista espanola de salud publica
Published: October 09, 2013
Last Updated: 09/26/2026